Medpace (MEDP) Competitors $472.94 -0.54 (-0.11%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$475.05 +2.11 (+0.45%) As of 05:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEDP vs. ICLR, EHC, ELV, HIMS, IQV, WCN, RDDT, TCOM, CPAY, and TOSTShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include Icon (ICLR), Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), Waste Connections (WCN), Reddit (RDDT), Trip.com Group (TCOM), Corpay (CPAY), and Toast (TOST). Medpace vs. Its Competitors Icon Encompass Health Elevance Health Hims & Hers Health IQVIA Waste Connections Reddit Trip.com Group Corpay Toast Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment. Which has more volatility and risk, MEDP or ICLR? Medpace has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Which has stronger earnings & valuation, MEDP or ICLR? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B6.30$404.39M$13.4535.16Icon$8.09B1.75$791.47M$9.7218.01 Does the media prefer MEDP or ICLR? In the previous week, Medpace had 20 more articles in the media than Icon. MarketBeat recorded 25 mentions for Medpace and 5 mentions for Icon. Medpace's average media sentiment score of 1.30 beat Icon's score of 0.43 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 20 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is MEDP or ICLR more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Icon 9.82%10.95%6.23% Do insiders & institutionals hold more shares of MEDP or ICLR? 78.0% of Medpace shares are held by institutional investors. Comparatively, 95.6% of Icon shares are held by institutional investors. 20.3% of Medpace shares are held by company insiders. Comparatively, 44.0% of Icon shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts rate MEDP or ICLR? Medpace currently has a consensus target price of $406.60, suggesting a potential downside of 14.03%. Icon has a consensus target price of $218.38, suggesting a potential upside of 24.76%. Given Icon's stronger consensus rating and higher possible upside, analysts plainly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 3 Sell rating(s) 9 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93Icon 0 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 2.75 SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.30B$7.69B$5.78B$9.79BDividend YieldN/A2.73%3.95%4.02%P/E Ratio35.1678.2431.2426.59Price / Sales6.3045.60429.49156.00Price / Cash33.9424.7637.7359.36Price / Book77.0321.7310.366.68Net Income$404.39M$242.04M$3.27B$265.59M7 Day Performance2.01%-0.92%1.40%0.62%1 Month Performance5.59%2.64%6.21%2.61%1 Year Performance29.24%9.98%46.60%22.34% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.2219 of 5 stars$472.94-0.1%$406.60-14.0%+24.1%$13.30B$2.11B35.165,900News CoveragePositive NewsInsider TradeICLRIcon4.0963 of 5 stars$178.56+1.5%$219.54+22.9%-45.4%$14.42B$8.28B18.3741,900EHCEncompass Health4.6322 of 5 stars$120.26-0.1%$134.00+11.4%+34.7%$12.11B$5.37B23.5340,000Positive NewsInsider TradeELVElevance Health4.8901 of 5 stars$310.03+0.1%$413.81+33.5%-43.7%$69.81B$177.01B13.19104,200Positive NewsHIMSHims & Hers Health2.7562 of 5 stars$45.15-1.9%$38.92-13.8%+201.7%$10.20B$1.48B56.441,637Trending NewsInsider TradeIQVIQVIA4.9108 of 5 stars$192.58+0.8%$228.62+18.7%-23.8%$32.74B$15.41B27.8788,000Positive NewsWCNWaste Connections4.5328 of 5 stars$184.88+0.1%$215.00+16.3%-1.1%$47.77B$8.92B74.5523,854RDDTReddit2.8545 of 5 stars$241.76-1.9%$171.83-28.9%+302.0%$46.13B$1.67B219.782,233Insider TradeTCOMTrip.com Group3.4786 of 5 stars$62.95+0.9%$77.25+22.7%+62.5%$41.12B$7.30B18.2541,073News CoveragePositive NewsAnalyst ForecastOptions VolumeCPAYCorpay3.6192 of 5 stars$316.90-0.2%$396.33+25.1%+7.1%$22.38B$3.97B21.5311,200Positive NewsTOSTToast3.239 of 5 stars$42.47-1.6%$45.54+7.2%+89.0%$21.66B$4.96B124.915,700Positive News Related Companies and Tools Related Companies Icon Alternatives Encompass Health Alternatives Elevance Health Alternatives Hims & Hers Health Alternatives IQVIA Alternatives Waste Connections Alternatives Reddit Alternatives Trip.com Group Alternatives Corpay Alternatives Toast Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEDP) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access